BIOLINE RXBIOLINE RXBIOLINE RX

BIOLINE RX

No trades
See on Supercharts

BLRX fundamentals

BIOLINE RX financial statements, including revenue, expenses, profit, and loss

The total revenue of BLRX for the last quarter is 25.12 M ILS, and it's 36.91% higher compared to the previous quarter. The net income of Q1 24 is -2.55 M ILS.

Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: ILS
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth